Arthrotec for all?
作者信息
Cullen D, Hawkey C J
机构信息
Department of Medicine, University Hospital, Queen's Medical Centre, Nottingham, United Kingdom.
出版信息
Ann Rheum Dis. 1993 Dec;52(12):841-2. doi: 10.1136/ard.52.12.841.
Abstract
摘要
相似文献
1
Arthrotec for all?
Ann Rheum Dis. 1993 Dec;52(12):841-2. doi: 10.1136/ard.52.12.841.
2
Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.对乙酰氨基酚双氯芬酸75与萘丁美酮在发生非甾体抗炎药诱导的胃肠道溃疡高风险骨关节炎患者中的上消化道安全性比较。
Clin Ther. 1999 Apr;21(4):659-74. doi: 10.1016/s0149-2918(00)88318-6.
3
Recurrence of Arthrotec-associated nephrotic syndrome with re-challenge.使用Arthrotec再次激发后，Arthrotec相关性肾病综合征复发。
Clin Nephrol. 2000 Jun;53(6):483-5.
4
5
Non-steroidal anti-inflammatory drugs.非甾体抗炎药。
Clin Evid. 2002 Dec(8):1203-11.
6
Review of Arthrotec clinical data.阿罗刻临床数据综述。
Eur J Rheumatol Inflamm. 1994;14(3 Suppl):25-9.
7
Capsule endoscopy and nonsteroidal anti-inflammatory drugs (NSAID)-induced enteropathy--a bit of light in a long, dark tunel.胶囊内镜与非甾体抗炎药（NSAID）诱发的肠病——漫长黑暗隧道中的一丝曙光
Rev Esp Enferm Dig. 2010 Feb;102(2):73-9. doi: 10.4321/s1130-01082010000200001.
8
Non-steroidal anti-inflammatory drugs.非甾体抗炎药。
Clin Evid. 2002 Jun(7):1063-70.
9
Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.罗非昔布（万络）和奥湿克的耐受性概况。骨关节炎患者六周治疗的比较。
Scand J Rheumatol. 2001;30(1):19-24. doi: 10.1080/030097401750065274.
10
[3 questions about gastrointestinal risk. Are coxibs here clearly better than NSAID?]].关于胃肠道风险有3个问题。环氧化酶-2选择性抑制剂在这里明显比非甾体抗炎药更好吗？
MMW Fortschr Med. 2006 Nov 30;148(48):12.
本文引用的文献
1
Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy.非甾体抗炎药治疗中消化性溃疡并发症风险的差异。
Arthritis Rheum. 1993 Jan;36(1):84-90. doi: 10.1002/art.1780360114.
2
Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial.米索前列醇预防非甾体抗炎药引起的胃溃疡：多中心、双盲、安慰剂对照试验。
Lancet. 1988 Dec 3;2(8623):1277-80. doi: 10.1016/s0140-6736(88)92892-9.
3
Rising frequency of ulcer perforation in elderly people in the United Kingdom.英国老年人溃疡穿孔发生率上升。
Lancet. 1986 Mar 1;1(8479):489-92. doi: 10.1016/s0140-6736(86)92940-5.
4
Geographic and temporal variations in the occurrence of peptic ulcer disease.
Scand J Gastroenterol Suppl. 1985;110:11-24. doi: 10.3109/00365528509095826.
5
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.奥美拉唑和雷尼替丁对良性胃溃疡患者溃疡愈合及复发率的影响。
N Engl J Med. 1989 Jan 12;320(2):69-75. doi: 10.1056/NEJM198901123200201.
6
Non-steroidal anti-inflammatory drugs and peptic ulcers.非甾体抗炎药与消化性溃疡
BMJ. 1990 Feb 3;300(6720):278-84. doi: 10.1136/bmj.300.6720.278.
7
Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.
Ann Intern Med. 1991 Feb 15;114(4):257-63. doi: 10.7326/0003-4819-114-4-257.
8
The relative toxicity of nonsteroidal antiinflammatory drugs.
Arthritis Rheum. 1991 Nov;34(11):1353-60. doi: 10.1002/art.1780341103.
9
Non-steroidal anti-inflammatory drug usage and requirement in elderly acute hospital admissions.老年急性住院患者非甾体抗炎药的使用情况及需求
Br J Rheumatol. 1992 Jan;31(1):45-8. doi: 10.1093/rheumatology/31.1.45.
10
Treatment of nonsteroidal anti-inflammatory drug-induced gastropathy.非甾体抗炎药所致胃病的治疗
Clin Pharm. 1992 Aug;11(8):690-704.
Zotero 插件